M42, a global tech-enabled health powerhouse, has partnered with one of the world’s leading children’s hospitals, Great Ormond Street Hospital for Children (GOSH), in London, part of the National Health Service (NHS) in the United Kingdom.
Under the partnership, they will introduce an innovative education initiative to enhance pediatric critical and complex care in the region, focusing on M42’s Danat Al Emarat Hospital for Women and Children, a pioneer in UAE’s pediatric health.
This collaboration will also explore numerous research and innovation projects, including advancing genomics and pioneering cell and gene therapy approaches, aligning with M42’s role as the UAE’s Emirati Genome Program facilitator. Other areas of exploration may include machine learning and AI, such as M42’s generative AI language model, Med42.
Ashish Koshy Group COO – M42
“Through collaborations such as this, M42 is impactfully disrupting global health. We see our partnership with Great Ormond Street Hospital as an opportunity to take pediatric health to a new level in the region and reset best practices globally. By combining GOSH’s world-class solutions with M42’s innovative health solutions, we are positioning ourselves to make a difference, further strengthening M42’s clinical operations and reshaping excellence for children’s health.”
Through this partnership, M42’s Danat Al Emarat Hospital for Women and Children will be empowered to cater to specific health conditions with unprecedented precision and excellence, ensuring an even higher level of care for its young patients. The collaboration will streamline patient care by establishing a robust joint Multidisciplinary Team (MDT) approach between Danat Al Emarat and GOSH, a second opinion framework, and a visiting consultant program.
With Level 3 Neonatal Intensive Care Unit (NICU) and Paediatric Intensive Care Unit (PICU) facilities at Danat Al Emarat Hospital, the innovative partnership with GOSH will enhance the quality of pediatric and neonatal critical care.
Globally acclaimed for its expertise in treating children with rare and complex medical conditions, GOSH compliments M42’s mission to impactfully transform global health. This multifaceted collaboration will support children with complex medical conditions in the initial phase through education programs, with a vision to extend the partnerships to include genomics and research. Together, they aim to advance genomics and cell and gene therapy.
